Beyond LIS and LIMS: coordinated orders and results management

Extending laboratory reach beyond the hospital works best with the integration of specialised surrounding solutions. Here, in a moderated session, thought-leaders from Sunquest and CliniSys Group explore the benefits of purpose-built technology.

Human papillomavirus: current open-access research interest

Vaccination against human papillomavirus (HPV) infection has proved to reduce the incidence of cervical cancer by nearly 90%. Research into all aspects of HPV-related disease continues as the following examples illustrate.

Higher-specificity D-dimer scores in health technology assessment

Recent studies have supported a D-dimer assay role in ruling out venous thromboembolism and pulmonary embolism, linking it to health technology assessment savings, as Gillian Eyre explains.

Acute respiratory tract infections: a paradigm shift in diagnosis

Acute respiratory tract infections are a significant burden on healthcare services. Here, Carolyne Horner considers an alternative approach to diagnosis in which a change in human immune response is the focus of detection.

Diagnostics in the UK: building a sector that is fit for the future

Following publication of a report compiled by Roche Diagnostics, three leading experts who contributed to the document discuss the impact that the SARS-CoV-2 pandemic has had on the industry, the challenges ahead, and their visions for the future.

Innovation in sepsis management: rapid POC host response testing

Sepsis is a life-threatening reaction to an infection, resulting in the immune system overreacting and the beginning of damage to the body’s own tissues and organs. Here, Charlotte Duncan introduces the latest in point-of-care technology.

SARS-CoV-2 and COVID-19 disease: current open-access research interest

The coronavirus pandemic has stimulated research effort around the world and has been instrumental in emphasising the importance of open-access peer-reviewed publication. The following examples are all available through PubMed Central (PMC).

Getting cancer services back on track: a diagnostics sector role

Healthcare leaders are calling upon government and health providers to drastically scale-up and improve cancer services in the wake of the SARS-CoV-2 pandemic. This article provides an insight into some of the key recommendations for a recovery.

ScopioVet digital platform: a service revolutionising veterinary care

One of Europe’s leading medical diagnostics service providers has launched a ground-breaking new veterinary pathology solution that is set to revolutionise pet care across the UK, the Nordic countries and Europe, as two examples of its use illustrate

A rapid, automated HPLC and UHPLC method development system

Thermo Fisher Scientific and software provider ChromSword recently collaborated to launch an automated high-performance liquid chromatography and ultrahigh-performance liquid chromatography method development system.

Plenary to placements: a further look at the IBMS Congress 2022

Following specific coverage of the 2022 Biomedical Science Congress in previous issues of Pathology in Practice, this month the magazine looks at plenary aspects and some of those delivering the education, training and management programmes.

And now for something completely different… views from the industry

Recently, Mark Reed canvassed many of his colleagues for their views on how the industry is perceived generally, and what they believe the future holds for the commercial diagnostics sector.

Pernicious anaemia: testing, staging and advances in genetics

Pernicious anaemia is a common cause of vitamin B12 deficiency. Irrespective of the cause of the disease, the most well-defined consequence is disturbed blood cell production and resulting megaloblastic anaemia.

Issues in infection control: a look at the science of safe surfaces

Effective cleaning and disinfection protocols are vital to minimise the risk of cross-infection in hospitals. Kayleigh Cox-Nowak provides an insight into effective protocols to reduce the risk of transmission of healthcare-associated infections.

POCT Innovators champions POC, rapid and decentralised diagnostics

Tony Cambridge provides a brief overview of the development of POCT and his evolving role in this near-patient service, and introduces a new website, including interactive media, devoted to all aspects of rapid and decentralised diagnostics.

Blood coagulation EQA adopts webinar format during conference vacuum

Christopher Reilly-Stitt reports on two UK NEQAS BC webinars held in April and July, and the response received from an international online audience.

Loop-mediated isothermal amplification: from brucellosis to SARS-CoV-2

The development of new nucleic acid amplification techniques is bringing molecular diagnostics closer to the patient for faster results and improved patient management. A prime example of this latest near-patient capability is LAMP technology.

Identifying life-threatening VITT using a highly specific ELISA

Vaccine-induced immune thrombocytopenia and thrombosis has been identified as a rare side effect of the ChAdOx1 nCoV-19 adenoviral vector vaccine. Alex Stephenson-Brown explains how an ELISA from Stago can detect cases of the condition.

Digestive diseases: a review of the latest efficiencies in diagnostics

The SARS-CoV-2 pandemic has brought many challenges that have driven the need to manage patients differently. Amanda Appleton and Emma Isom explain how the increased use of novel diagnostic solutions has helped to address issues in gastroenterology.

Revolution in automation: the 1960s to the 21st-century laboratory

For over 50 years Sysmex has innovated and revolutionised the fields of haematology, haemostasis and urinalysis. Here, the company revisits some of the key landmarks in the history of Sysmex and how they have helped shape today's laboratories.

Latest Issues